By Tom Tango/The Associated PressDiatron, a medical device company that has a history of patent infringement lawsuits, has agreed to pay more than $6 billion to settle lawsuits filed by health insurers and others.
The deal with HealthCare.gov, a federal marketplace created by President Donald Trump’s signature health care legislation, will end an eight-year dispute that started in the early 1990s when Diatron sued two insurers in the U.-S.
Court of Federal Claims over the company’s Diatron Health Products.
The insurers were not the only ones with Diatron products.
The company agreed to settle the lawsuit in January 2018 and in December 2018 reached a settlement with two more insurers.
But it wasn’t the only Diatron lawsuit the company was involved in.
Diatron filed two others that have since been settled.
The first was with the U-S.
Department of Health and Human Services in 2012 and settled with the agency in June 2018.
Diatron was also sued by the federal government for alleged trademark infringement and deceptive practices by Diatron’s competitors.
The case was settled with Diaton in 2016.
Diacon said in a statement that it is pleased to resolve this dispute.
“As part of the settlement, Diatron will continue to sell its products in the United States through our U.K. business,” the statement said.
“This includes the Diatron Healthcare Products line of medical instruments and the Diatricity Medical Products line.”
The deal is part of Diatron Inc.’s $8 billion settlement with the government over a dispute over the sale of Diatrist devices, which it manufactures in Europe and other countries.